Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.
作者信息
Ruth Mike Marvin, Sangen Jasper Jan Nicolaas, Wertheim Heiman Frank Louis, van Ingen Jakko
机构信息
Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands
出版信息
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.01233-17. Print 2017 Sep.
Abstract
摘要
相似文献
1
Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.01233-17. Print 2017 Sep.
2
Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
Eur J Clin Microbiol. 1987 Aug;6(4):486-7. doi: 10.1007/BF02013117.
3
In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Antimicrob Agents Chemother. 2010 May;54(5):2188-90. doi: 10.1128/AAC.01603-09. Epub 2010 Mar 15.
4
Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
Diagn Microbiol Infect Dis. 1985 Jan;3(1):33-40. doi: 10.1016/0732-8893(85)90064-1.
5
[In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Immun Infekt. 1986 Nov;14(6):203-7.
6
New antimycobacterial S-alkylisothiosemicarbazones.
Folia Microbiol (Praha). 2005;50(6):479-81. doi: 10.1007/BF02931433.
7
Beta-lactam antibiotics and mycobacteria.
J Antimicrob Chemother. 1986 Jul;18(1):6-8. doi: 10.1093/jac/18.1.6.
8
Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
J Chemother. 1989 Feb;1(1):39-45. doi: 10.1080/1120009x.1989.11738862.
9
Preliminary study of the in vitro activity of irloxacin against mycobacteria.
Chemotherapy. 1995 May-Jun;41(3):204-7. doi: 10.1159/000239345.
10
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.
本文引用的文献
1
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
Int J Antimicrob Agents. 2017 May;49(5):554-557. doi: 10.1016/j.ijantimicag.2017.02.008. Epub 2017 Mar 21.
2
An update on the management of urinary tract infections in the era of antimicrobial resistance.
Postgrad Med. 2017 Mar;129(2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21.
3
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
Bioorg Med Chem Lett. 2016 Aug 1;26(15):3669-74. doi: 10.1016/j.bmcl.2016.05.088. Epub 2016 May 30.
4
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
Expert Rev Anti Infect Ther. 2013 Oct;11(10):1065-77. doi: 10.1586/14787210.2013.830413.
5
Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis.
Arch Dis Child. 2010 Mar;95(3):224-8. doi: 10.1136/adc.2008.157297. Epub 2009 Nov 29.
6
COLLATERAL SUSCEPTIBILITY OF ISONIAZID-RESISTANT TUBERCLE BACILLI TO NITROFURANS.
Am Rev Respir Dis. 1963 Nov;88:712-5. doi: 10.1164/arrd.1963.88.5.712.
7
Nitrofurantoin disposition.
Clin Pharmacol Ther. 1981 Jun;29(6):808-16. doi: 10.1038/clpt.1981.115.
8
Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome.
Antimicrob Agents Chemother. 1987 Oct;31(10):1579-84. doi: 10.1128/AAC.31.10.1579.
9
Pharmacokinetics of a nitrofuran compound, nifurtimox, in healthy volunteers.
Int J Clin Pharmacol Ther Toxicol. 1989 Sep;27(9):454-7.
Zotero 插件